Author Archive
-
Dec 24, 2024As the middlemen between drug companies and insurers, PBMs are shoo-ins as the villains behind high drug prices. But they do play a useful role in the health marketplace. -
Apr 25, 2024The dominance of group purchasing organizations (GPOs) is often cited as a cause of generic drug shortages. The problem is more complicated than that.
